BMC Research Notes (May 2023)

In vitro anti-Toxoplasma gondii activity of Ganoderma lucidum extracts

  • Mohammad ahmadi,
  • Mahboobeh Salimi,
  • Mehrzad Saraei,
  • Niloofar Salavati Nezhad,
  • Amir Javadi,
  • Faezeh Mohammadi,
  • Peyman Heydarian,
  • Ehsan Ali,
  • Elham Hajialilo

DOI
https://doi.org/10.1186/s13104-023-06355-6
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Objective Ganoderma extracts have the potential to be used as anti-cancer, anti-inflammatory, immunomodulator, and antimicrobial agents, as evaluated in numerous studies. This study was aimed to determine the lethal and inhibitory effects of aqueous, hydroalcoholic, and alcoholic extracts of Ganoderma lucidum on Toxoplasma gondii RH strain tachyzoites, in vitro. Results All three types of extracts showed toxoplasmacidal effects. The highest percentage of mortality was related to hydroalcoholic extract. The EC50 of Ganoderma extracts for tachyzoites were 76.32, 3.274, and 40.18 for aqueous, hydroalcoholic and alcoholic extracts, respectively. The selectivity index obtained for hydroalcoholic extract was 71.22, showing the highest activity compared to other extracts. According to our findings, the hydroalcoholic part was the most effective substance among the extracts. This basic study showed obvious anti-toxoplasma effect of Ganoderma lucidum extracts. These extracts can be used as candidates for further in-depth and comprehensive studies especially In vivo experiments to prevent toxoplasmosis.

Keywords